Last update 21 Nov 2024

YR-001

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Kv1.3
Mechanism
Kv1.3 blockers(Voltage-gated potassium channel subunit Kv1.3 blockers)
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases+ [1]
Active Indication
Mild Atopic DermatitisModerate Atopic DermatitisPsoriasis+ [3]
Inactive Indication-
Originator Organization
Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
Active Organization
Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with YR-001
NCT06309355 / RecruitingPhase 2
A Randomized, Placebo-controlled, Double-blind, Multi Center, Phase IIa Trial Investigating the Safety, Tolerability, Pharmacokinetics and Efficacy of Topical Ointment YR001 in Adult Patients With Mild to Moderate Atopic Dermatitis
NCT05718921 / CompletedPhase 1
A Randomized, Double-blind, Placebo-controlled Single and Multiple Dose Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Topical Ointment YR001 in Adult Healthy Volunteers
100 Clinical Results associated with YR-001
Login to view more data
100 Translational Medicine associated with YR-001
Login to view more data
100 Patents (Medical) associated with YR-001
Login to view more data
100 Deals associated with YR-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mild Atopic DermatitisPhase 2
US
Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
19 Jun 2024
Moderate Atopic DermatitisPhase 2
US
Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
19 Jun 2024
PsoriasisPhase 1
US
Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
08 Apr 2023
Dermatitis, AtopicIND Approval
CN
Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
20 Nov 2023
AlopeciaPreclinical
US
Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
06 Sep 2023
Inflammatory Bowel DiseasesPreclinical
US
Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
06 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free